CYTK CYTOKINETICS INC
Nasdaq · SEC CIK 1061983 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $52.26M 81 sales by 10 insiders
- Filings on record
- 559 since 2021-07-02, latest 2026-09-22 18:14
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Blum Robert I | Pres, CEO, Dir | — | $17.08M |
| Callos Andrew | EVP, Chief Commercial Off | — | $16.02M |
| Lee Sung | EVP, CFO | — | $5.70M |
| Malik Fady Ibraham | EVP Research, Development | — | $4.65M |
| Kaye Edward M. MD | Dir | — | $3.21M |
| HENDERSON JOHN T | Dir | — | $2.08M |
| WIERENGA WENDELL | Dir | — | $1.88M |
| PARSHALL B LYNNE | Dir | — | $1.36M |
| Landry Robert E | Dir | — | $146.8K |
| Harrington Robert Arthur | Dir | — | $143.6K |
Transactions 784
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-05 | 2024-12-03 | CYTK | Malik Fady Ibraham | EVP Research, Development | F - Tax | $51.51 | -2,028 | 114.1K | -2% | -$104.5K | |
| 2024-12-05 | 2024-12-03 | CYTK | Callos Andrew | EVP, Chief Commercial Off | F - Tax | $51.51 | -1,351 | 65.7K | -2% | -$69.6K | |
| M | 2024-12-05 | 2024-12-03 | CYTK | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +6,353 | 68.9K | +10% | $0 |
| M | 2024-12-05 | 2024-12-03 | CYTK | Wong Robert | VP, CAO | A - Grant | $0.00 | +1,530 | 18.7K | +9% | $0 |
| 2024-12-05 | 2024-12-03 | CYTK | Wong Robert | VP, CAO | F - Tax | $51.51 | -273 | 17.9K | -2% | -$14.1K | |
| D | 2024-12-02 | 2024-12-02 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $50.76 | -5,000 | 397.7K | -1% | -$253.8K |
| D | 2024-12-02 | 2024-12-02 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +5,000 | 402.7K | +1% | +$33.4K |
| D | 2024-11-26 | 2024-11-25 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $7.37 | +742 | 25.3K | +3% | +$5,469 |
| D | 2024-11-26 | 2024-11-25 | CYTK | WIERENGA WENDALL | Dir | S - Sale+OE | $50.00 | -742 | 24.6K | -3% | -$37.1K |
| D | 2024-11-26 | 2024-11-26 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 119.2K | +5% | +$42.2K |
| DM | 2024-11-26 | 2024-11-26 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $50.16 | -7,300 | 111.9K | -6% | -$366.2K |
| D | 2024-11-19 | 2024-11-18 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $50.55 | -5,000 | 397.5K | -1% | -$252.8K |
| D | 2024-11-19 | 2024-11-18 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +5,000 | 402.5K | +1% | +$33.4K |
| D | 2024-11-13 | 2024-11-12 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 120.2K | +5% | +$42.2K |
| DM | 2024-11-13 | 2024-11-12 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $58.48 | -6,342 | 114.9K | -5% | -$370.9K |
| D | 2024-11-04 | 2024-11-01 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $51.63 | -5,000 | 397.5K | -1% | -$258.1K |
| D | 2024-11-04 | 2024-11-01 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +5,000 | 402.5K | +1% | +$33.4K |
| D | 2024-10-31 | 2024-10-30 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 122.2K | +5% | +$42.2K |
| DM | 2024-10-31 | 2024-10-30 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $51.91 | -7,300 | 116.9K | -6% | -$378.9K |
| D | 2024-10-31 | 2024-10-28 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $7.37 | +4,452 | 29.0K | +18% | +$32.8K |
| D | 2024-10-31 | 2024-10-28 | CYTK | WIERENGA WENDALL | Dir | S - Sale+OE | $52.25 | -4,452 | 24.6K | -15% | -$232.6K |
| D | 2024-10-16 | 2024-10-15 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 124.2K | +4% | +$42.2K |
| DM | 2024-10-16 | 2024-10-15 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $54.19 | -7,300 | 118.9K | -6% | -$395.6K |
| D | 2024-10-10 | 2024-10-09 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $55.61 | -5,000 | 397.5K | -1% | -$278.1K |
| D | 2024-10-10 | 2024-10-09 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +5,000 | 402.5K | +1% | +$33.4K |
| 2024-10-03 | 2024-10-01 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $52.60 | +403 | 38.5K | +1% | +$21.2K | |
| 2024-10-03 | 2024-10-01 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $52.60 | +237 | 25.4K | +0.9% | +$12.5K | |
| 2024-10-03 | 2024-10-01 | CYTK | Harrington Robert Arthur | Dir | A - Grant | $52.60 | +237 | 15.8K | +2% | +$12.5K | |
| 2024-10-03 | 2024-10-01 | CYTK | Wysenski Nancy | Dir | A - Grant | $52.60 | +118 | 23.0K | +0.5% | +$6,207 | |
| 2024-10-03 | 2024-10-01 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $52.60 | +118 | 24.6K | +0.5% | +$6,207 | |
| DM | 2024-10-01 | 2024-10-01 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $52.10 | -7,300 | 118.9K | -6% | -$380.3K |
| D | 2024-10-01 | 2024-10-01 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 124.2K | +4% | +$42.2K |
| D | 2024-09-30 | 2024-09-30 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $52.14 | -5,000 | 397.5K | -1% | -$260.7K |
| D | 2024-09-30 | 2024-09-30 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +5,000 | 402.5K | +1% | +$33.4K |
| DM | 2024-09-17 | 2024-09-17 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $56.77 | -7,300 | 122.9K | -6% | -$414.4K |
| D | 2024-09-17 | 2024-09-17 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 128.2K | +4% | +$42.2K |
| D | 2024-09-17 | 2024-09-16 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +5,000 | 402.5K | +1% | +$33.4K |
| D | 2024-09-17 | 2024-09-16 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $55.99 | -5,000 | 397.5K | -1% | -$279.9K |
| D | 2024-09-09 | 2024-09-09 | CYTK | PARSHALL B LYNNE | Dir | S - Sale+OE | $54.92 | -5,000 | 20.6K | -20% | -$274.6K |
| D | 2024-09-09 | 2024-09-09 | CYTK | PARSHALL B LYNNE | Dir | M - OptEx | $21.61 | +5,000 | 25.6K | +24% | +$108.0K |
| D | 2024-09-03 | 2024-08-30 | CYTK | Pletcher Brett A | EVP, CLO | A - Grant | $0.00 | +33.1K | 33.1K | New | $0 |
| D | 2024-09-03 | 2024-09-03 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +5,000 | 402.5K | +1% | +$33.4K |
| D | 2024-09-03 | 2024-09-03 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $57.03 | -5,000 | 397.5K | -1% | -$285.1K |
| DM | 2024-09-03 | 2024-09-03 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $57.01 | -7,384 | 122.9K | -6% | -$421.0K |
| D | 2024-09-03 | 2024-09-03 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 128.2K | +4% | +$42.2K |
| D | 2024-08-26 | 2024-08-26 | CYTK | PARSHALL B LYNNE | Dir | S - Sale+OE | $57.26 | -5,000 | 20.6K | -20% | -$286.3K |
| D | 2024-08-26 | 2024-08-26 | CYTK | PARSHALL B LYNNE | Dir | M - OptEx | $21.61 | +5,000 | 25.6K | +24% | +$108.0K |
| D | 2024-08-22 | 2024-08-20 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 130.3K | +4% | +$42.2K |
| DM | 2024-08-22 | 2024-08-20 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $56.25 | -7,300 | 125.0K | -6% | -$410.6K |
| 2024-08-19 | 2024-08-19 | CYTK | Blum Robert I | Pres, CEO, Dir | G - Gift | $0.00 | -1,956 | 397.5K | -0.5% | $0 | |
| D | 2024-08-12 | 2024-08-12 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $55.17 | -11.5K | 399.4K | -3% | -$634.5K |
| D | 2024-08-12 | 2024-08-12 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +11.5K | 410.9K | +3% | +$76.7K |
| D | 2024-08-12 | 2024-08-12 | CYTK | PARSHALL B LYNNE | Dir | M - OptEx | $21.61 | +5,000 | 25.6K | +24% | +$108.0K |
| D | 2024-08-12 | 2024-08-12 | CYTK | PARSHALL B LYNNE | Dir | S - Sale+OE | $55.20 | -5,000 | 20.6K | -20% | -$276.0K |
| DM | 2024-08-07 | 2024-08-06 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $53.71 | -7,300 | 121.7K | -6% | -$392.1K |
| D | 2024-08-07 | 2024-08-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 127.0K | +4% | +$42.2K |
| D | 2024-07-31 | 2024-07-30 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +11.5K | 410.9K | +3% | +$76.7K |
| D | 2024-07-31 | 2024-07-30 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $59.49 | -11.5K | 399.4K | -3% | -$684.1K |
| D | 2024-07-31 | 2024-07-29 | CYTK | PARSHALL B LYNNE | Dir | M - OptEx | $21.61 | +5,000 | 25.6K | +24% | +$108.0K |
| D | 2024-07-31 | 2024-07-29 | CYTK | PARSHALL B LYNNE | Dir | S - Sale+OE | $59.84 | -5,000 | 20.6K | -20% | -$299.2K |
| DM | 2024-07-23 | 2024-07-23 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $57.02 | -7,300 | 129.0K | -5% | -$416.2K |
| D | 2024-07-23 | 2024-07-23 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 134.3K | +4% | +$42.2K |
| D | 2024-07-16 | 2024-07-15 | CYTK | PARSHALL B LYNNE | Dir | S - Sale+OE | $55.82 | -5,000 | 20.6K | -20% | -$279.1K |
| D | 2024-07-16 | 2024-07-15 | CYTK | PARSHALL B LYNNE | Dir | M - OptEx | $10.68 | +5,000 | 25.6K | +24% | +$53.4K |
| D | 2024-07-10 | 2024-07-10 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $54.29 | -11.5K | 399.4K | -3% | -$624.3K |
| D | 2024-07-10 | 2024-07-10 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +5,767 | 410.9K | +1% | +$38.5K |
| DM | 2024-07-09 | 2024-07-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $55.90 | -7,300 | 133.0K | -5% | -$408.1K |
| D | 2024-07-09 | 2024-07-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 138.3K | +4% | +$42.2K |
| 2024-07-08 | 2024-07-05 | CYTK | Harrington Robert Arthur | Dir | S - Sale | $54.61 | -253 | 15.5K | -2% | -$13.8K | |
| 2024-07-03 | 2024-07-01 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $0.00 | +114 | 24.4K | +0.5% | $0 | |
| 2024-07-03 | 2024-07-01 | CYTK | Harrington Robert Arthur | Dir | A - Grant | $0.00 | +228 | 15.8K | +1% | $0 | |
| 2024-07-03 | 2024-07-01 | CYTK | Wysenski Nancy | Dir | A - Grant | $0.00 | +114 | 22.9K | +0.5% | $0 | |
| 2024-07-03 | 2024-07-01 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $0.00 | +228 | 25.1K | +0.9% | $0 | |
| 2024-07-03 | 2024-07-01 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $0.00 | +388 | 38.1K | +1% | $0 | |
| D | 2024-07-01 | 2024-07-01 | CYTK | PARSHALL B LYNNE | Dir | M - OptEx | $10.68 | +5,000 | 25.6K | +24% | +$53.4K |
| D | 2024-07-01 | 2024-07-01 | CYTK | PARSHALL B LYNNE | Dir | S - Sale+OE | $54.22 | -5,000 | 20.6K | -20% | -$271.1K |
| 2024-07-01 | 2024-07-01 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale | $54.05 | -11.5K | 405.1K | -3% | -$621.6K | |
| DM | 2024-06-25 | 2024-06-25 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $53.72 | -7,300 | 133.0K | -5% | -$392.1K |
| D | 2024-06-25 | 2024-06-25 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,300 | 138.3K | +4% | +$42.2K |
| D | 2024-06-17 | 2024-06-17 | CYTK | PARSHALL B LYNNE | Dir | M - OptEx | $10.68 | +5,000 | 25.6K | +24% | +$53.4K |
| D | 2024-06-17 | 2024-06-17 | CYTK | PARSHALL B LYNNE | Dir | S - Sale+OE | $52.55 | -5,000 | 20.6K | -20% | -$262.8K |
| M | 2024-06-17 | 2024-06-17 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale | $52.60 | -22.5K | 416.6K | -5% | -$1.18M |
| D | 2024-06-11 | 2024-06-11 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $7.96 | +5,422 | 142.8K | +4% | +$43.2K |
| DM | 2024-06-11 | 2024-06-11 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $53.04 | -7,788 | 135.0K | -5% | -$413.1K |
| 2024-06-10 | 2024-06-10 | CYTK | Bhanji Muna | Dir | S - Sale | $52.07 | -2,000 | 17.6K | -10% | -$104.1K | |
| 2024-06-07 | 2024-06-04 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale | $48.85 | -22.5K | 439.1K | -5% | -$1.10M | |
| 2024-06-05 | 2024-06-03 | CYTK | Harrington Robert Arthur | Dir | S - Sale | $48.64 | -1,580 | 15.5K | -9% | -$76.9K | |
| D | 2024-06-04 | 2024-06-03 | CYTK | PARSHALL B LYNNE | Dir | M - OptEx | $10.68 | +5,000 | 20.6K | +32% | +$53.4K |
| D | 2024-06-04 | 2024-06-03 | CYTK | PARSHALL B LYNNE | Dir | S - Sale+OE | $48.64 | -5,000 | 15.6K | -24% | -$243.2K |
| D | 2024-06-03 | 2024-05-31 | CYTK | Lee Sung | EVP, CFO | A - Grant | $0.00 | +34.7K | 34.7K | New | $0 |
| 2024-06-03 | 2024-06-03 | CYTK | Wong Robert | VP, CAO | S - Sale | $48.88 | -13.0K | 16.7K | -44% | -$636.0K | |
| D | 2024-05-16 | 2024-05-15 | CYTK | PARSHALL B LYNNE | Dir | A - Grant | $0.00 | +5,600 | 20.6K | +37% | $0 |
| D | 2024-05-16 | 2024-05-15 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $0.00 | +5,600 | 37.7K | +17% | $0 |
| D | 2024-05-16 | 2024-05-15 | CYTK | WIERENGA WENDALL | Dir | A - Grant | $0.00 | +5,600 | 24.3K | +30% | $0 |
| D | 2024-05-16 | 2024-05-15 | CYTK | Kaye Edward M. MD | Dir | A - Grant | $0.00 | +5,600 | 24.9K | +29% | $0 |
| D | 2024-05-16 | 2024-05-15 | CYTK | COSTA SANTO J | Dir | A - Grant | $0.00 | +5,600 | 20.6K | +37% | $0 |
| D | 2024-05-16 | 2024-05-15 | CYTK | Harrington Robert Arthur | Dir | A - Grant | $0.00 | +5,600 | 17.1K | +49% | $0 |
| D | 2024-05-16 | 2024-05-15 | CYTK | Bhanji Muna | Dir | A - Grant | $0.00 | +5,600 | 19.6K | +40% | $0 |
| D | 2024-05-16 | 2024-05-15 | CYTK | Wysenski Nancy | Dir | A - Grant | $0.00 | +5,600 | 22.8K | +33% | $0 |
| D | 2024-05-07 | 2024-05-07 | CYTK | Malik Fady Ibraham | EVP Research, Development | M - OptEx | $6.67 | +14.2K | 152.6K | +10% | +$94.6K |
Purchase Sale Sale after option exercise All abbreviations